REGULATION OF THE PRODUCTION OF PRO-INFLAMMATORY CYTOKINES AND ANTAGONISTS DURING CHEMOTHERAPY-INDUCED NEUTROPENIA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
Nej. Denecker et al., REGULATION OF THE PRODUCTION OF PRO-INFLAMMATORY CYTOKINES AND ANTAGONISTS DURING CHEMOTHERAPY-INDUCED NEUTROPENIA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, Cytokine, 9(9), 1997, pp. 702-710
Cytokine profiles were studied during 19 episodes of chemotherapy-indu
ced neutropenia in 17 patients with haematological malignancies. Circu
lating concentrations of interleukin 1 alpha (IL-1 alpha), tumour necr
osis factor alpha (TNF-alpha) and IL-1 receptor antagonist (IL-1ra) we
re measured before chemotherapy and thereafter three times weekly, Dur
ing and after chemotherapy no significant changes were found in circul
ating cytokines. After start of chemotherapy, the ex-vivo LPS-stimulat
ed production of cytokines in whole blood decreased and subsequently d
isappeared completely in all patients, and recovered after the end of
treatment. The decrease of cytokine production could not be attributed
to the decreased number of cells only, as the net production per circ
ulating neutrophil or monocyte also decreased significantly, and was r
estored after completion of chemotherapy. These results show that the
production of IL-1 beta, TNF-alpha and IL-1ra in blood disappears duri
ng chemotherapy-induced neutropenia, not only due to the decreased num
ber of producing cells, but also as a result of a decreased production
per cell, suggesting a mechanism of downregulation. (C) 1997 Academic
Press Limited.